Assessment of Exenatide Extended-Release for Maintenance of Diabetic Remission in Cats
Exenatide-ER contributed to the maintenance of glycemic control as reflected by hemoglobin A1c but did not affect remission duration. Management might have contributed to the extended remission duration.
Authors
- Charlotte Reinhard Bjørnvad (ORCID: https://orcid.org/0000-0002-2876-1667)
- Audrey K. Cook (ORCID: https://orcid.org/0000-0002-2840-6497)
- Adam J. Rudinsky (ORCID: https://orcid.org/0000-0001-5369-3152)
- L. M. Fleeman (ORCID: https://orcid.org/0000-0001-5732-7889)
- Jocelyn Mott (ORCID: https://orcid.org/0000-0002-2176-9287)
- Katarina Hazuchova (ORCID: https://orcid.org/0000-0002-7185-0446)
- Allison L. O’Kell (ORCID: https://orcid.org/0000-0002-3412-0575)
- Sean E. Hulsebosch (ORCID: https://orcid.org/0000-0003-0684-0871)
- Stijn Niessen (ORCID: https://orcid.org/0009-0000-9667-6678)
- Jully Pires (ORCID: https://orcid.org/0009-0007-5063-1045)
- Chen Gilor (ORCID: https://orcid.org/0000-0003-0393-4135)
- Ruth Gostelow (ORCID: https://orcid.org/0000-0001-9354-8291)
Institutions
- University of Copenhagen (DK)
- Royal Veterinary College (GB)
- University of Hertfordshire (GB)
- Justus-Liebig-Universität Gießen (DE)
- Diabetes Australia (AU)
- Frederiksberg Hospital (DK)
- Texas College (US)
- University of Florida (US)
- Vinitex Laboratory Systems (Netherlands) (NL)
- HPO Center (Netherlands) (NL)
- The Ohio State University (US)
- University of California, Davis (US)
- Texas A&M University (US)
- Florida College (US)
Publication Details
- Journal
- Journal of Veterinary Internal Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/jvim.70069
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.18
Funders
- Morris Animal Foundation
- Ohio State University
- Dechra Veterinary Products